• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    AbbVie Inc. (ABBV)

    -NYSE
    67.71 0.21(0.31%) Dec 19, 4:06PM EST
    |After Hours : 68.49 Up 0.78 (1.15%) Dec 19, 7:58PM EST
    Add to Portfolio
    Prev Close:67.92
    Open:67.75
    Bid:60.01 x 100
    Ask:70.40 x 100
    1y Target Est:69.57
    Beta:1.928
    Next Earnings Date:30-Jan-15ABBV Earnings announcement
    Day's Range:66.84 - 68.62
    52wk Range:45.50 - 70.76
    Volume:12,631,038
    Avg Vol (3m):12,326,000
    Market Cap:107.88B
    P/E (ttm):29.44
    EPS (ttm):2.30
    Div & Yield:1.96 (2.90%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 0.31%107.88B
    MRK169.86B
    NVS228.83B
    PFE201.24B

    Key Statistics

    Forward P/E (1 yr):15.89
    P/S (ttm):5.52
    Ex-Dividend Date:13-Jan-15

    Analysts

    Annual EPS Est (Dec-14) :3.30
    Quarterly EPS Est (Dec-14) :0.86
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.63

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback